OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Effectiveness of Antidiabetic Drugs in Treating Dementia: A Peek into Pharmacological and Pharmacokinetic Properties
Jiro Ogura, Hiroaki Yamaguchi
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 12, pp. 6542-6542
Open Access | Times Cited: 8

Showing 8 citing articles:

Thiazolidinedione use is associated with reduced risk of dementia in patients with type 2 diabetes mellitus: A retrospective cohort study
Houyu Zhao, Lin Zhuo, Yexiang Sun, et al.
Journal of Diabetes (2023) Vol. 15, Iss. 2, pp. 97-109
Open Access | Times Cited: 16

Emerging Evidence for the Use of Antidiabetic Drugs, Glucagon-like Peptide 1 Receptor Agonists, for the Treatment of Alzheimer’s Disease
Ides M. Colin, Lidia W Szczepanski, A Gérard, et al.
touchREVIEWS in Endocrinology (2023) Vol. 19, Iss. 1, pp. 16-16
Open Access | Times Cited: 11

Targeting Ferroptosis in Parkinson’s: Repurposing Diabetes Drugs as a Promising Treatment
C. Duta, Corina Muscurel, Carmen Beatrice Dogaru, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 4, pp. 1516-1516
Open Access

Association of insomnia with incident chronic cognitive impairment in older adults with type 2 diabetes mellitus: A prospective study of the Hong Kong Diabetes Register
O Chun-Kwan, Brian Siu, Vanessa Wai-Shan Leung, et al.
Journal of Diabetes and its Complications (2023) Vol. 37, Iss. 10, pp. 108598-108598
Closed Access | Times Cited: 5

Dipeptidyl peptidase-4 inhibitors alleviate cognitive dysfunction in type 2 diabetes mellitus
Jie Meng, Rui Yan, Chen Zhang, et al.
Lipids in Health and Disease (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 5

Type 2 diabetes drug glitazone may help lowering risk of dementia by 22%
Areeba Fareed, Samia Rohail, Ateeba Kamran
Annals of Medicine and Surgery (2023) Vol. 85, Iss. 4, pp. 1296-1297
Open Access

Page 1

Scroll to top